Exelixis, Inc.
EXELNASDAQHealthcare● Active
$52.51
+$0.77(+1.49%)
Market Cap$13.2B
P/E Ratio—
52W High$53.24
52W Low$33.76
Exelixis, Inc.（EXEL）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EXEL · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2026-01 | 2025-01 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $1.06B | $1.11B | $1.00B | $1.31B | $1.47B |
| Net Receivables | $0.29B | $0.27B | $0.24B | $0.21B | $0.28B |
| Inventory | $0.02B | $0.02B | $0.02B | $0.03B | $0.03B |
| Total Current Assets | $1.44B | $1.47B | $1.32B | $1.62B | $1.83B |
| PP&E Net | $0.44B | $0.36B | $0.47B | $0.35B | $0.10B |
| Goodwill | $0.06B | $0.06B | $0.06B | $0.06B | $0.06B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.03B | $0.04B | $0.03B | $0.03B | $0.02B |
| Total Current Liabilities | $0.41B | $0.40B | $0.39B | $0.32B | $0.34B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.68B | $0.70B | $0.68B | $0.58B | $0.41B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.08B) | ($0.10B) | ($0.17B) | ($0.03B) | ($0.22B) |
| Total Stockholders Equity | $2.16B | $2.24B | $2.26B | $2.49B | $2.21B |
| Total Liab & Equity(computed) | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B |
| Debt Summary | |||||
| Total Debt | $0.17B | $0.19B | $0.19B | $0.19B | $0.05B |
| Net Debt | ($0.31B) | ($0.03B) | ($0.07B) | ($0.31B) | ($0.60B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Exelixis, Inc.
关于Exelixis, Inc.（EXEL）资产负债表
Exelixis, Inc.总资产$2.84B，现金及短期投资$1.06B，总负债$0.68B，总债务$0.17B，股东权益$2.16B。
常见问题
EXEL · 4 问Exelixis, Inc.总债务$0.17B，净债务($0.31B)。
EXEL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10